Request Sample Inquiry
Radiopharmaceuticals Market

Radiopharmaceuticals Market

Radiopharmaceuticals Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

148

Base Year:

2022

Date

May - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2143

Segments Covered
  • By Type By Type Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals, Technetium-99m, Thallium-201, Gallium-67, Iodine-123, Other, PET Radiopharmaceuticals, F-18, RU-82, Others, Therapeutic Nuclear Medicine, Alpha Emitters, Ra-223, Brachytherapy Isotopes, Intoiodine-125, Palladium-103, Cesium-131, Iridium-192, Other brachytherapy isotopes, Beta Emitters, Intoiodine-131, Yttrium-90, Samarium-153, Lutetium-177, Rhenium-186, Other beta emitters
  • By Application By Application Diagnostic Applications, SPECT Applications, Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications, PET applications, Oncology, Cardiology, Neurology, Other PET applications, Therapeutic Applications, Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Indications
  • By Procedural Volume Assessment By Procedural Volume Assessment Diagnostic Procedures, Therapeutic Procedures, Source
  • By Source By Source Nuclear Reactors, Cyclotrons
  • By End User By End User Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 5.2 Billion
Revenue 2030Revenue 2030: USD 9.75 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 9.4%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Radiopharmaceuticals Market - Segment Analysis
    1. Overview
    2. Global Radiopharmaceuticals Market, 2016 - 2028 (USD Million)
    3. Global Radiopharmaceuticals Market - by Type
      1. By Diagnostic Nuclear Medicine
      2. By SPECT Radiopharmaceuticals
      3. By Technetium-99m
      4. By Thallium-201
      5. By Gallium-67
      6. By Iodine-123
      7. By Other
      8. By PET Radiopharmaceuticals
      9. By F-18
      10. By RU-82
      11. By Others
      12. By Therapeutic Nuclear Medicine
      13. By Alpha Emitters
      14. By Ra-223
      15. By Brachytherapy Isotopes
      16. By Intoiodine-125
      17. By Palladium-103
      18. By Cesium-131
      19. By Iridium-192
      20. By Other brachytherapy isotopes
      21. By Beta Emitters
      22. By Intoiodine-131
      23. By Yttrium-90
      24. By Samarium-153
      25. By Lutetium-177
      26. By Rhenium-186
      27. By Other beta emitters
    4. Global Radiopharmaceuticals Market - by Application
      1. By Diagnostic Applications
      2. By SPECT Applications
      3. By Cardiology
      4. By Bone Scans
      5. By Thyroid Applications
      6. By Pulmonary Scans
      7. By Other SPECT Applications
      8. By PET applications
      9. By Oncology
      10. By Cardiology
      11. By Neurology
      12. By Other PET applications
      13. By Therapeutic Applications
      14. By Thyroid Indications
      15. By Bone Metastasis
      16. By Lymphoma
      17. By Endocrine Tumors
      18. By Other Indications
    5. Global Radiopharmaceuticals Market - by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
      3. By Source
    6. Global Radiopharmaceuticals Market - by Source
      1. By Nuclear Reactors
      2. By Cyclotrons
    7. Global Radiopharmaceuticals Market - by End User
      1. By Hospitals
      2. By Ambulatory Surgical Centers
      3. By Diagnostic Centers
      4. By Cancer Research Institutes
      5. By Others
    8. Global Radiopharmaceuticals Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    9. Market comparative analysis
  4. North America Radiopharmaceuticals Market - Segment Analysis
    1. Overview
    2. North America Radiopharmaceuticals Market, 2016 - 2028 (USD Million)
    3. North America Radiopharmaceuticals Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By SPECT Radiopharmaceuticals
      3. By Technetium-99m
      4. By Thallium-201
      5. By Gallium-67
      6. By Iodine-123
      7. By Other
      8. By PET Radiopharmaceuticals
      9. By F-18
      10. By RU-82
      11. By Others
      12. By Therapeutic Nuclear Medicine
      13. By Alpha Emitters
      14. By Ra-223
      15. By Brachytherapy Isotopes
      16. By Intoiodine-125
      17. By Palladium-103
      18. By Cesium-131
      19. By Iridium-192
      20. By Other brachytherapy isotopes
      21. By Beta Emitters
      22. By Intoiodine-131
      23. By Yttrium-90
      24. By Samarium-153
      25. By Lutetium-177
      26. By Rhenium-186
      27. By Other beta emitters
    4. North America Radiopharmaceuticals Market, by Application
      1. By Diagnostic Applications
      2. By SPECT Applications
      3. By Cardiology
      4. By Bone Scans
      5. By Thyroid Applications
      6. By Pulmonary Scans
      7. By Other SPECT Applications
      8. By PET applications
      9. By Oncology
      10. By Cardiology
      11. By Neurology
      12. By Other PET applications
      13. By Therapeutic Applications
      14. By Thyroid Indications
      15. By Bone Metastasis
      16. By Lymphoma
      17. By Endocrine Tumors
      18. By Other Indications
    5. North America Radiopharmaceuticals Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
      3. By Source
    6. North America Radiopharmaceuticals Market, by Source
      1. By Nuclear Reactors
      2. By Cyclotrons
    7. North America Radiopharmaceuticals Market, by End User
      1. By Hospitals
      2. By Ambulatory Surgical Centers
      3. By Diagnostic Centers
      4. By Cancer Research Institutes
      5. By Others
    8. North America Radiopharmaceuticals Market, by Country
      1. U.S.
        1. U.S. Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. U.S. Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. U.S. Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. U.S. Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. U.S. Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      2. Canada
        1. Canada Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Canada Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Canada Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Canada Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Canada Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      3. Mexico
        1. Mexico Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Mexico Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Mexico Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Mexico Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Mexico Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
  5. Europe Radiopharmaceuticals Market - Segment Analysis
    1. Overview
    2. Europe Radiopharmaceuticals Market, 2016 - 2028 (USD Million)
    3. Europe Radiopharmaceuticals Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By SPECT Radiopharmaceuticals
      3. By Technetium-99m
      4. By Thallium-201
      5. By Gallium-67
      6. By Iodine-123
      7. By Other
      8. By PET Radiopharmaceuticals
      9. By F-18
      10. By RU-82
      11. By Others
      12. By Therapeutic Nuclear Medicine
      13. By Alpha Emitters
      14. By Ra-223
      15. By Brachytherapy Isotopes
      16. By Intoiodine-125
      17. By Palladium-103
      18. By Cesium-131
      19. By Iridium-192
      20. By Other brachytherapy isotopes
      21. By Beta Emitters
      22. By Intoiodine-131
      23. By Yttrium-90
      24. By Samarium-153
      25. By Lutetium-177
      26. By Rhenium-186
      27. By Other beta emitters
    4. Europe Radiopharmaceuticals Market, by Application
      1. By Diagnostic Applications
      2. By SPECT Applications
      3. By Cardiology
      4. By Bone Scans
      5. By Thyroid Applications
      6. By Pulmonary Scans
      7. By Other SPECT Applications
      8. By PET applications
      9. By Oncology
      10. By Cardiology
      11. By Neurology
      12. By Other PET applications
      13. By Therapeutic Applications
      14. By Thyroid Indications
      15. By Bone Metastasis
      16. By Lymphoma
      17. By Endocrine Tumors
      18. By Other Indications
    5. Europe Radiopharmaceuticals Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
      3. By Source
    6. Europe Radiopharmaceuticals Market, by Source
      1. By Nuclear Reactors
      2. By Cyclotrons
    7. Europe Radiopharmaceuticals Market, by End User
      1. By Hospitals
      2. By Ambulatory Surgical Centers
      3. By Diagnostic Centers
      4. By Cancer Research Institutes
      5. By Others
    8. Europe Radiopharmaceuticals Market, by Country
      1. Germany
        1. Germany Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Germany Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Germany Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Germany Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Germany Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      2. UK
        1. UK Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. UK Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. UK Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. UK Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. UK Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      3. France
        1. France Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. France Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. France Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. France Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. France Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      4. Spain
        1. Spain Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Spain Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Spain Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Spain Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Spain Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      5. Italy
        1. Italy Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Italy Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Italy Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Italy Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Italy Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      6. BENELUX
        1. BENELUX Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. BENELUX Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. BENELUX Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. BENELUX Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. BENELUX Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      7. Rest of Europe
        1. Rest Of Europe Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Rest Of Europe Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Rest Of Europe Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Rest Of Europe Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Rest Of Europe Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
  6. Asia Pacific Radiopharmaceuticals Market - Segment Analysis
    1. Overview
    2. Asia Pacific Radiopharmaceuticals Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Radiopharmaceuticals Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By SPECT Radiopharmaceuticals
      3. By Technetium-99m
      4. By Thallium-201
      5. By Gallium-67
      6. By Iodine-123
      7. By Other
      8. By PET Radiopharmaceuticals
      9. By F-18
      10. By RU-82
      11. By Others
      12. By Therapeutic Nuclear Medicine
      13. By Alpha Emitters
      14. By Ra-223
      15. By Brachytherapy Isotopes
      16. By Intoiodine-125
      17. By Palladium-103
      18. By Cesium-131
      19. By Iridium-192
      20. By Other brachytherapy isotopes
      21. By Beta Emitters
      22. By Intoiodine-131
      23. By Yttrium-90
      24. By Samarium-153
      25. By Lutetium-177
      26. By Rhenium-186
      27. By Other beta emitters
    4. Asia Pacific Radiopharmaceuticals Market, by Application
      1. By Diagnostic Applications
      2. By SPECT Applications
      3. By Cardiology
      4. By Bone Scans
      5. By Thyroid Applications
      6. By Pulmonary Scans
      7. By Other SPECT Applications
      8. By PET applications
      9. By Oncology
      10. By Cardiology
      11. By Neurology
      12. By Other PET applications
      13. By Therapeutic Applications
      14. By Thyroid Indications
      15. By Bone Metastasis
      16. By Lymphoma
      17. By Endocrine Tumors
      18. By Other Indications
    5. Asia Pacific Radiopharmaceuticals Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
      3. By Source
    6. Asia Pacific Radiopharmaceuticals Market, by Source
      1. By Nuclear Reactors
      2. By Cyclotrons
    7. Asia Pacific Radiopharmaceuticals Market, by End User
      1. By Hospitals
      2. By Ambulatory Surgical Centers
      3. By Diagnostic Centers
      4. By Cancer Research Institutes
      5. By Others
    8. Asia Pacific Radiopharmaceuticals Market, by Country
      1. China
        1. China Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. China Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. China Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. China Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. China Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      2. Japan
        1. Japan Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Japan Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Japan Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Japan Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Japan Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      3. India
        1. India Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. India Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. India Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. India Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. India Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      4. South Korea
        1. South Korea Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. South Korea Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. South Korea Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. South Korea Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. South Korea Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      5. South East Asia
        1. South East Asia Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. South East Asia Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. South East Asia Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. South East Asia Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. South East Asia Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Rest of Asia Pacific Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Rest of Asia Pacific Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Rest of Asia Pacific Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Rest of Asia Pacific Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
  7. Latin America Radiopharmaceuticals Market - Segment Analysis
    1. Overview
    2. Latin America Radiopharmaceuticals Market, 2016 - 2028 (USD Million)
    3. Latin America Radiopharmaceuticals Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By SPECT Radiopharmaceuticals
      3. By Technetium-99m
      4. By Thallium-201
      5. By Gallium-67
      6. By Iodine-123
      7. By Other
      8. By PET Radiopharmaceuticals
      9. By F-18
      10. By RU-82
      11. By Others
      12. By Therapeutic Nuclear Medicine
      13. By Alpha Emitters
      14. By Ra-223
      15. By Brachytherapy Isotopes
      16. By Intoiodine-125
      17. By Palladium-103
      18. By Cesium-131
      19. By Iridium-192
      20. By Other brachytherapy isotopes
      21. By Beta Emitters
      22. By Intoiodine-131
      23. By Yttrium-90
      24. By Samarium-153
      25. By Lutetium-177
      26. By Rhenium-186
      27. By Other beta emitters
    4. Latin America Radiopharmaceuticals Market, by Application
      1. By Diagnostic Applications
      2. By SPECT Applications
      3. By Cardiology
      4. By Bone Scans
      5. By Thyroid Applications
      6. By Pulmonary Scans
      7. By Other SPECT Applications
      8. By PET applications
      9. By Oncology
      10. By Cardiology
      11. By Neurology
      12. By Other PET applications
      13. By Therapeutic Applications
      14. By Thyroid Indications
      15. By Bone Metastasis
      16. By Lymphoma
      17. By Endocrine Tumors
      18. By Other Indications
    5. Latin America Radiopharmaceuticals Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
      3. By Source
    6. Latin America Radiopharmaceuticals Market, by Source
      1. By Nuclear Reactors
      2. By Cyclotrons
    7. Latin America Radiopharmaceuticals Market, by End User
      1. By Hospitals
      2. By Ambulatory Surgical Centers
      3. By Diagnostic Centers
      4. By Cancer Research Institutes
      5. By Others
    8. Latin America Radiopharmaceuticals Market, by Country
      1. Brazil
        1. Brazil Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Brazil Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Brazil Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Brazil Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Brazil Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      2. Argentina
        1. Argentina Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Argentina Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Argentina Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Argentina Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Argentina Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      3. Rest of Latin America
        1. Rest of Latin America Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Rest of Latin America Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Rest of Latin America Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Rest of Latin America Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Rest of Latin America Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
  8. Middle East & Africa Radiopharmaceuticals Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Radiopharmaceuticals Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Radiopharmaceuticals Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By SPECT Radiopharmaceuticals
      3. By Technetium-99m
      4. By Thallium-201
      5. By Gallium-67
      6. By Iodine-123
      7. By Other
      8. By PET Radiopharmaceuticals
      9. By F-18
      10. By RU-82
      11. By Others
      12. By Therapeutic Nuclear Medicine
      13. By Alpha Emitters
      14. By Ra-223
      15. By Brachytherapy Isotopes
      16. By Intoiodine-125
      17. By Palladium-103
      18. By Cesium-131
      19. By Iridium-192
      20. By Other brachytherapy isotopes
      21. By Beta Emitters
      22. By Intoiodine-131
      23. By Yttrium-90
      24. By Samarium-153
      25. By Lutetium-177
      26. By Rhenium-186
      27. By Other beta emitters
    4. Middle East & Africa Radiopharmaceuticals Market, by Application
      1. By Diagnostic Applications
      2. By SPECT Applications
      3. By Cardiology
      4. By Bone Scans
      5. By Thyroid Applications
      6. By Pulmonary Scans
      7. By Other SPECT Applications
      8. By PET applications
      9. By Oncology
      10. By Cardiology
      11. By Neurology
      12. By Other PET applications
      13. By Therapeutic Applications
      14. By Thyroid Indications
      15. By Bone Metastasis
      16. By Lymphoma
      17. By Endocrine Tumors
      18. By Other Indications
    5. Middle East & Africa Radiopharmaceuticals Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
      3. By Source
    6. Middle East & Africa Radiopharmaceuticals Market, by Source
      1. By Nuclear Reactors
      2. By Cyclotrons
    7. Middle East & Africa Radiopharmaceuticals Market, by End User
      1. By Hospitals
      2. By Ambulatory Surgical Centers
      3. By Diagnostic Centers
      4. By Cancer Research Institutes
      5. By Others
    8. Middle East & Africa Radiopharmaceuticals Market, by Country
      1. GCC Countries
        1. GCC Countries Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. GCC Countries Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. GCC Countries Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. GCC Countries Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. GCC Countries Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      2. South Africa
        1. South Africa Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. South Africa Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. South Africa Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. South Africa Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. South Africa Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Radiopharmaceuticals Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By SPECT Radiopharmaceuticals
          3. By Technetium-99m
          4. By Thallium-201
          5. By Gallium-67
          6. By Iodine-123
          7. By Other
          8. By PET Radiopharmaceuticals
          9. By F-18
          10. By RU-82
          11. By Others
          12. By Therapeutic Nuclear Medicine
          13. By Alpha Emitters
          14. By Ra-223
          15. By Brachytherapy Isotopes
          16. By Intoiodine-125
          17. By Palladium-103
          18. By Cesium-131
          19. By Iridium-192
          20. By Other brachytherapy isotopes
          21. By Beta Emitters
          22. By Intoiodine-131
          23. By Yttrium-90
          24. By Samarium-153
          25. By Lutetium-177
          26. By Rhenium-186
          27. By Other beta emitters
        2. Rest of Middle East & Africa Radiopharmaceuticals Market, By Application
          1. By Diagnostic Applications
          2. By SPECT Applications
          3. By Cardiology
          4. By Bone Scans
          5. By Thyroid Applications
          6. By Pulmonary Scans
          7. By Other SPECT Applications
          8. By PET applications
          9. By Oncology
          10. By Cardiology
          11. By Neurology
          12. By Other PET applications
          13. By Therapeutic Applications
          14. By Thyroid Indications
          15. By Bone Metastasis
          16. By Lymphoma
          17. By Endocrine Tumors
          18. By Other Indications
        3. Rest of Middle East & Africa Radiopharmaceuticals Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
          3. By Source
        4. Rest of Middle East & Africa Radiopharmaceuticals Market, By Source
          1. By Nuclear Reactors
          2. By Cyclotrons
        5. Rest of Middle East & Africa Radiopharmaceuticals Market, By End User
          1. By Hospitals
          2. By Ambulatory Surgical Centers
          3. By Diagnostic Centers
          4. By Cancer Research Institutes
          5. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Cardinal Health (U.S.)
    2. GE Healthcare (U.S.)
    3. Lantheus Medical Imaging (U.S.)
    4. Bayer AG (Germany)
    5. Bracco Imaging (Italy)
    6. Nordion (Canada)
    7. Advanced Accelerator Applications (France)
    8. NTP Radioisotopes (South Africa)
    9. NorthStar Medical Radioisotopes (U.S.)
    10. Eckert & Ziegler (Germany)
    11. Braun Melsungen AG (Germany)
    12. Smith+Nephew (Germany)
    13. Zimmer Biomet (U.S.)
    14. Hanger Inc. (U.S.) and Otto Bock Healthcare GmBH (Germany)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 24-May-2023
Radiopharmaceuticals Market to Reach Valuation of USD 9.75 Billion by 2028 – Growth in the Adoption of Cloud and Big Data Drives the Market
FAQ
Frequently Asked Question

  • The global Radiopharmaceuticals valued at USD 5.2 Billion in 2022 and is expected to reach USD 9.75 Billion in 2030 growing at a CAGR of 9.4%.

  • The prominent players in the market are Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), Bracco Imaging (Italy), Nordion (Canada), Advanced Accelerator Applications (France), NTP Radioisotopes (South Africa), NorthStar Medical Radioisotopes (U.S.), Eckert & Ziegler (Germany), Braun Melsungen AG (Germany), Smith+Nephew (Germany), Zimmer Biomet (U.S.), Hanger Inc. (U.S.) and Otto Bock Healthcare GmBH (Germany).

  • The market is project to grow at a CAGR of 9.4% between 2023 and 2030.

  • The driving factors of the Radiopharmaceuticals include

    • Increasing Cases of Cancer and Heart Diseases

  • North America was the leading regional segment of the Radiopharmaceuticals in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy